Evidence map›Paper›PMID 35620541›Full record

ReviewHealth science reports2022

COVID-19 mortality and its predictors in the elderly: A systematic review.

Omid Dadras, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Ahmadreza Shamsabadi, Kowsar Qaderi, Maryam Ramezani, Seyed Peyman Mirghaderi, Sara Mahdiabadi, Farzin Vahedi, Solmaz Saeidi and 5 more

RetractedErratum issuedOpen access · goldAbstract readReviewRetracted Publication
In one paragraph

Review in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 81 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 5 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 5 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Older persons' knowledge of HIV and AIDS prevention in a province of South Africa.African journal of primary health care & family medicine · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Omid DadrasIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran Iran.ORCID https://orcid.org/0000-0001-9385-2170
SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran Iran.ORCID https://orcid.org/0000-0003-3210-7905
Amirali KarimiSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Ahmadreza ShamsabadiDepartment of Health Information Technology Esfarayen Faculty of Medical Sciences Esfarayen Iran.
Kowsar QaderiKermanshah University of Medical Sciences Kermanshah Iran.
Maryam RamezaniDepartment of Health Management, Policy and Economics School of Public Health, Tehran University of Medical Sciences Tehran Iran.
Seyed Peyman MirghaderiSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Sara MahdiabadiSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Farzin VahediSchool of Medicine Tehran University of Medical Sciences Tehran Iran.
Solmaz SaeidiDepartment of Nursing University of Medical Sciences; Khalkhal Khalkhal Iran.
Alireza ShojaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors Tehran Iran.
Mohammad MehrtakSchool of Medicine and Allied Medical Sciences Ardabil University of Medical Sciences Ardabil Iran.
Shiva A AzarSchool of Pharmacy Shiraz University of Medical Sciences Shiraz Iran.
Esmaeil MehraeenDepartment of Health Information Technology Khalkhal University of Medical Sciences Khalkhal Iran.ORCID https://orcid.org/0000-0003-4108-2973
Fabrício A VoltarelliGraduation Program in Health Sciences Faculty of Medicine, Federal University of Mato Grosso Cuiabá Mato Grosso Brazil.
Tehran University of Medical Sciences · IRIranian Institute for Health Sciences Research · IRLorestan University of Medical Sciences · IRArdabil University of Medical Sciences · IREsfarayen University of Technology · IRKermanshah University of Medical Sciences · IRShiraz University of Medical Sciences · IRUniversidade Federal de Mato Grosso · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Older people have higher rates of comorbidities and may experience more severe inflammatory responses; therefore, are at higher risk of death. Herein, we aimed to systematically review the mortality in coronavirus disease 2019 (COVID-19) patients and its predictors in this age group. Methods: We searched PubMed, Web of Science, and Science Direct using relevant keywords. Retrieved records underwent a two-step screening process consisting of title/abstract and full-text screenings to identify the eligible studies. Results: Summarizing findings of 35 studies demonstrated that older patients have higher mortality rates compared to the younger population. A review of articles revealed that increasing age, body mass index, a male gender, dementia, impairment or dependency in daily activities, presence of consolidations on chest X-ray, hypoxemic respiratory failure, and lower oxygen saturation at admission were risk factors for death. High d-dimer levels, 25-hydroxy vitamin D serum deficiencies, high C-reactive protein (≥5 mg/L) levels plus any other abnormalities of lymphocyte, higher blood urea nitrogen or lactate dehydrogenase, and higher platelet count were predictors of poor prognosis and mortality in the elderly. Studies have also shown that previous treatment with renin-angiotensin-aldosterone system inhibitors, pharmacological treatments of respiratory disorders, antibiotics, corticosteroids, vitamin K antagonist, antihistamines, azithromycin, Itolizumab (an anti-CD6 monoclonal antibody) in combination with other antivirals reduces COVID-19 worsening and mortality. Vaccination against seasonal influenza might also reduce COVID-19 mortality. Conclusion: Overall, a critical consideration is necessary for the care and management of COVID-19 in the aged population considering the drastic contrasts in manifestation and prognosis compared to other age groups. Mortality from COVID-19 is independently associated with the patient's age. Elderly patients with COVID-19 are more vulnerable to poor outcomes. Thus, strict preventive measures, timely diagnosis, and aggressive therapeutic/nontherapeutic care are of great importance to reduce acute respiratory distress syndrome and severe complications in older people.

Indexed as

agingCOVID‐19elderlyolder peopleSARS‐CoV‐2

Identifiers

PMID35620541
PMCPMC9125886
OpenAlexW4281297761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.